SCOPUS 정보 검색 플랫폼

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 11, 2006, Pages 1201-1202

Rituximab Responsive Refractory Acute Graft-versus-Host Disease

(3) Kamble, R a Oholendt, M a Carrum, G a

a HOUSTON METHODIST HOSPITAL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYCLOPHOSPHAMIDE; DACLIZUMAB; FLUDARABINE; INFLIXIMAB; MELPHALAN; MEPREDNISONE; METHOTREXATE; PREDNISONE; RITUXIMAB; STEROID; TSUKUBAENOLIDE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; B CELL LYMPHOMA; B LYMPHOCYTE; BRAIN DISEASE; BRAIN EDEMA; CASE REPORT; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; KIDNEY FAILURE; LARGE CELL LYMPHOMA; LETTER; LYMPHOCYTE DEPLETION; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLASMAPHERESIS; SEIZURE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT FAILURE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 33750511373 PISSN: 10838791 EISSN: 15236536 Source Type: Journal
DOI: 10.1016/j.bbmt.2006.06.013 Document Type: Letter

Times cited : (24)

References (5)

1
- 3843103590
- Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
- Ho V.T., Zahrieh D., Hochberg E., et al. Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood 104 (2004) 1224-1226
- (2004) Blood , vol.104 , pp. 1224-1226
- Ho, V.T.¹ Zahrieh, D.² Hochberg, E.³

2
- 4644356472
- Novel approaches to the therapy of steroid resistant acute graft versus host disease
- Antin J.H., Chen A.R., Couriel D.R., Ho V.T., Nash R.A., and Weisdorf D. Novel approaches to the therapy of steroid resistant acute graft versus host disease. Biol Blood Marrow Transplant 10 (2004) 655-668
- (2004) Biol Blood Marrow Transplant , vol.10 , pp. 655-668
- Antin, J.H.¹ Chen, A.R.² Couriel, D.R.³ Ho, V.T.⁴ Nash, R.A.⁵ Weisdorf, D.⁶

3
- 4944225787
- Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease
- Canninga-van Dijk M.R., van der Straaten H.M., Fijnheer R., Sanders C.J., van den Tweel J.G., and Verdonck L.F. Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease. Blood 104 (2004) 2603-2606
- (2004) Blood , vol.104 , pp. 2603-2606
- Canninga-van Dijk, M.R.¹ van der Straaten, H.M.² Fijnheer, R.³ Sanders, C.J.⁴ van den Tweel, J.G.⁵ Verdonck, L.F.⁶

4
- 33745964855
- Rituximab for steroid-refractory chronic graft-vs.-host disease
- In press
- Cutler C., Miklos D., Kim H.T., et al. Rituximab for steroid-refractory chronic graft-vs.-host disease. Blood (2006) In press
- (2006) Blood
- Cutler, C.¹ Miklos, D.² Kim, H.T.³

5
- 24744472059
- Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases
- Fakhouri F., Vernant J.P., Veyradier A., et al. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases. Blood 106 (2005) 1932-1937
- (2005) Blood , vol.106 , pp. 1932-1937
- Fakhouri, F.¹ Vernant, J.P.² Veyradier, A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.